Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Ewing’s sarcoma : Discovery of a "link" in tumor growth

23.09.2004


When cells express the abnormal protein… In these cells, the blue, green and yellow labeling respectively corresponds to the nucleus, the abnormal protein EWS/FLI-1 and the protein IGFBP-3. In the cells where EWS/FLI-1 is present (green labeling), IGFBP-3 is absent (no yellow labeling), confirming that EWS/FLI1 prevents expression of the IGFBP-3 gene. A. Prieur/Institut Curie


To develop new therapeutic approaches to cancer, it is essential to understand the long and extremely complex process that underlies it, in other words the various stages of cancer development from the initial mutation to the tumor. Having already identified the alteration that leads to Ewing’s sarcoma, a bone cancer which afflicts young people, an Inserm team at the Institut Curie has recently used a combination of novel techniques to show that there 86 deregulated genes in these tumors. One of these genes, a new “link” in the development of Ewing’s sarcoma, could be used as a therapeutic target. These discoveries were published in the August 2004 issue of Molecular and Cellular Biology.

Cancer results from the proliferation of abnormal cells in the body. The trigger is an alteration in the genetic material of a single cell, in certain genes that regulate vital processes (division, differentiation, apoptosis, repair). However, a single mutation is not enough to transform a health cell into a cancer cell. Rather it is a succession of genetic accidents that results in uncontrolled cells that accumulate and lead to tumor formation.

Few cancers have a simple molecular signature – a specific mutation that leads to tumor growth. In Ewing’s sarcoma, a malignant tumor of the bone which affects children, teenagers and young adults, this molecular signature has been discovered thanks to a close collaboration between physicians and researchers at the Institut Curie, the internationally renowned reference center for the study and treatment of Ewing’s sarcoma.



Olivier Delattre(1) and his group have identified and characterized this mutation: it arises from an accidental exchange of genetic material between two chromosomes. This leads to the formation of a mutated gene that produces an abnormal protein called EWS/FLI-1 (see box overleaf). To understand the growth of Ewing’s sarcoma, Delattre and colleagues are now studying the effects of EWS/FLI-1 on the cellular machinery. They use an original approach in which the technique of RNA interference(2) is used to “switch off” the mutated gene. The abnormal protein is therefore no longer produced. Using DNA chips, they have studied how other genes are affected by the absence of the abnormal protein.

When a "brake" on proliferation is released…

With this combination of innovative techniques, Delattre and colleagues have identified 86 genes whose expression is altered in the absence of the abnormal protein. They have paid particular attention to one of these genes – the IGFBP-3 gene – whose expression is greatly reduced in tumor cells but which is again expressed normally when the altered protein is absent. The protein produced by the IGFBP-3 gene is known to block one of the most important cellular messengers, insulin-like growth factor 1. IGF-1 controls several fundamental mechanisms such as cellular proliferation and apoptosis (cell death). Overexpression of IGF-1 has, moreover, been implicated in certain cancers.

The Institut Curie researchers have thus shown in Ewing’s sarcoma that the altered protein prevents expression of the IGFBP-3 gene. As a consequence, IGF-1 is no longer "blocked" and so emits a continuous signal ordering the cells to proliferate. IGFBP-3 plays a role upstream in this signaling pathway and could be targeted therapeutically to block IGF-1-induced abnormal cellular proliferation.

Olivier Delattre and his team at the Institut Curie have therefore discovered a new “link” in the growth of Ewing’s sarcoma. Through better comprehension of the cascades of deregulations specific to each tumor, it will be possible to develop new therapeutic strategies that are better targeted and hence more effective.

Catherine Goupillon | alfa
Further information:
http://www.curie.fr
http://mcb.asm.org

More articles from Life Sciences:

nachricht A novel socio-ecological approach helps identifying suitable wolf habitats
17.02.2017 | Universität Zürich

nachricht New, ultra-flexible probes form reliable, scar-free integration with the brain
16.02.2017 | University of Texas at Austin

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Breakthrough with a chain of gold atoms

In the field of nanoscience, an international team of physicists with participants from Konstanz has achieved a breakthrough in understanding heat transport

In the field of nanoscience, an international team of physicists with participants from Konstanz has achieved a breakthrough in understanding heat transport

Im Focus: DNA repair: a new letter in the cell alphabet

Results reveal how discoveries may be hidden in scientific “blind spots”

Cells need to repair damaged DNA in our genes to prevent the development of cancer and other diseases. Our cells therefore activate and send “repair-proteins”...

Im Focus: Dresdner scientists print tomorrow’s world

The Fraunhofer IWS Dresden and Technische Universität Dresden inaugurated their jointly operated Center for Additive Manufacturing Dresden (AMCD) with a festive ceremony on February 7, 2017. Scientists from various disciplines perform research on materials, additive manufacturing processes and innovative technologies, which build up components in a layer by layer process. This technology opens up new horizons for component design and combinations of functions. For example during fabrication, electrical conductors and sensors are already able to be additively manufactured into components. They provide information about stress conditions of a product during operation.

The 3D-printing technology, or additive manufacturing as it is often called, has long made the step out of scientific research laboratories into industrial...

Im Focus: Mimicking nature's cellular architectures via 3-D printing

Research offers new level of control over the structure of 3-D printed materials

Nature does amazing things with limited design materials. Grass, for example, can support its own weight, resist strong wind loads, and recover after being...

Im Focus: Three Magnetic States for Each Hole

Nanometer-scale magnetic perforated grids could create new possibilities for computing. Together with international colleagues, scientists from the Helmholtz Zentrum Dresden-Rossendorf (HZDR) have shown how a cobalt grid can be reliably programmed at room temperature. In addition they discovered that for every hole ("antidot") three magnetic states can be configured. The results have been published in the journal "Scientific Reports".

Physicist Dr. Rantej Bali from the HZDR, together with scientists from Singapore and Australia, designed a special grid structure in a thin layer of cobalt in...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Booth and panel discussion – The Lindau Nobel Laureate Meetings at the AAAS 2017 Annual Meeting

13.02.2017 | Event News

Complex Loading versus Hidden Reserves

10.02.2017 | Event News

International Conference on Crystal Growth in Freiburg

09.02.2017 | Event News

 
Latest News

Biocompatible 3-D tracking system has potential to improve robot-assisted surgery

17.02.2017 | Medical Engineering

Real-time MRI analysis powered by supercomputers

17.02.2017 | Medical Engineering

Antibiotic effective against drug-resistant bacteria in pediatric skin infections

17.02.2017 | Health and Medicine

VideoLinks
B2B-VideoLinks
More VideoLinks >>>